BioCryst Pharmaceuticals Inc (BCRX)
7.825
+0.12
(+1.62%)
USD |
NASDAQ |
Jan 06, 16:00
7.825
0.00 (0.00%)
After-Hours: 17:52
BioCryst Pharmaceuticals Total Liabilities (Quarterly): 959.82M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 10.68M |
| Perspective Therapeutics Inc | 62.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Electromed Inc | 7.427M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 491.25M |
| Shareholders Equity (Quarterly) | -468.56M |
| Debt to Equity Ratio | -1.699 |
| Current Ratio | 2.781 |
| Net Debt Paydown Yield | 0.29% |